The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Ceftriaxone Once Daily for Four Weeks Compared with Ceftriaxone Plus Gentamicin Once Daily for Two Weeks for Treatment of Endocarditis Due to Penicillin-Susceptible Streptococci
Abstract
This randomized, multicenter, open-label study compared the efficacy and safety of monotherapy with 2 g of intravenous ceftriaxone once daily for 4 weeks with those of combination therapy with 2 g of intravenous ceftriaxone and 3 mg of intravenous gentamicin/kg once daily for 2 weeks as therapy for endocarditis due to penicillin-susceptible streptococci. Sixty-one patients were enrolled in the study. Clinical cure was observed for 51 evaluable patients both at termination of therapy and at the 3-month follow-up: 25 (96.2%) of 26 monotherapy recipients and 24 (96%) of 25 combination therapy recipients. Of the 23 patients in each treatment group who were microbiologically evaluable, 22 (95.7%) in each group were considered cured. No patient had evidence of relapse. Fourteen patients (27.5%) required cardiac surgery after initiation of treatment, including five monotherapy recipients and nine combination therapy recipients. Adverse effects were minimal in both treatment groups. We conclude that 2 g of ceftriaxone once daily for 4 weeks and 2 g of ceftriaxone in combination with 3 mg of gentamicin/kg once daily for 2 weeks are both effective and safe for the treatment of streptococcal endocarditis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Self-citationWilson, W. R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530210060032 · Cited by 492
Self-citationBrogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1979) · Drugs · doi:10.2165/00003495-197917040-00001 · Cited by 311
Doern, G. V., Ferraro, M. J., Brueggemann, A. B., & Ruoff, K. L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.4.891 · Cited by 294
Francioli, P., Ruch, W., Stamboulian, D., & International Infective Endocarditis Study Group (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1406 · Cited by 147
Pharmacokinetic profile of ceftriaxone in man.
Patel, I. H., & Kaplan, S. A. (1984) · PubMed · Cited by 128
Antibiotic Management of Outpatients with Endocarditis Due to Penicillin-Susceptible Streptococci
Stamboulián, D., Bonvehí, P., Arévalo, C. E., Bologna, R., Cassetti, I., Scilingo, V. M., & Efrón, E. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s160 · Cited by 126
Once-Daily Administration of Aminoglycosides
Bates, R. D., & Nahata, M. C. (1994) · Annals of Pharmacotherapy · doi:10.1177/106002809402800614 · Cited by 55
Single Daily Dosing of Aminoglycosides
Preston, S. L., & Briceland, L. L. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04368.x · Cited by 51
Bayer, A. S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.2.303 · Cited by 33
Research works printed but not linked: 4
- Etienne J, 1989, Pennsylvania: National Comtherapy, 35, 9
- Doern GV, 1996, Antimicrob Agents Chemother, 40, 4
- Patel IH, 1984, J Med, 19, 25
- Richards DM, 1994, Am J Hosp Pharm, 57, 21
Cited by
Sorted by citations
2015 ESC Guidelines for the management of infective endocarditis
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J., Zotti, F. D., Dulgheru, R., Khoury, G. A. E., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 5,086
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Self-citationPrevention of Infective Endocarditis
Wilson, W. R., Taubert, K. A., Gewitz, M. H., Lockhart, P. B., Baddour, L. M., Levison, M. E., Bolger, A. F., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.183095 · Cited by 2,807
Self-citationGuidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
2023 ESC Guidelines for the management of endocarditis
Delgado, V., Marsan, N. A., de Waha, S., Bonaros, N. E., Brida, M., Burri, H., Caselli, S., Doenst, T., Éderhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 2,039
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Self-citationInfective Endocarditis in Adults
Mylonakis, E. E., & Calderwood, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010082 · Cited by 1,332
Guidelines on Prevention, Diagnosis and Treatment of Infective Endocarditis Executive Summary
Horstkotte, D., Follath, F., Gutschik, E., Lengyel, M., Oto, A., Pavie, A., Soler‐Soler, J., Thiene, G., von Graevenitz, A., Priori, S. G., et al. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.008 · Cited by 718
Challenges in Infective Endocarditis
Cahill, T. J., Baddour, L. M., Habib, G., Hoen, B., Salaün, E., Pettersson, G., Schäfers, H., & Prendergast, B. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.066 · Cited by 724
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N. (2004) · Clinical Infectious Diseases · doi:10.1086/420939 · Cited by 532
Self-citationHoen, B., & Duval, X. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1206782 · Cited by 518
Prevention of infective endocarditis: Guidelines from the American Heart Association
Wilson, W. R., Taubert, K. A., Gewitz, M. H., Lockhart, P. B., Baddour, L. M., Levison, M. E., Bolger, A. F., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2008) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2008.0346 · Cited by 481
Self-citationPaul, M., Benuri‐Silbiger, I., Soares‐Weiser, K., & Leibovici, L. (2004) · BMJ · doi:10.1136/bmj.38028.520995.63 · Cited by 467
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miró, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 466
Infective Endocarditis in Childhood: 2015 Update
Baltimore, R. S., Gewitz, M. H., Baddour, L. M., Beerman, L. B., Jackson, M. A., Lockhart, P. B., Pahl, E., Schutze, G. E., Shulman, S. T., & Willoughby, R. E. (2015) · Circulation · doi:10.1161/cir.0000000000000298 · Cited by 396
Paul, M., Lador, A., Grozinsky‐Glasberg, S., & Leibovici, L. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub3 · Cited by 388
Prevention of infective endocarditis: Guidelines from the American Heart Association
Wilson, W. R., Taubert, K. A., Gewitz, M. H., Lockhart, P. B., Baddour, L. M., Levison, M. E., Bolger, A. F., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2007) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2007.0262 · Cited by 347
Self-citationUnique Features of Infective Endocarditis in Childhood
Ferrieri, P., Gewitz, M. H., Gerber, M. A., Newburger, J. W., Dajani, A. S., Shulman, S. T., Wilson, W. R., Bolger, A. F., Bayer, A. S., Levison, M. E., et al. (2002) · Circulation · doi:10.1161/01.cir.0000013073.22415.90 · Cited by 276
Self-citationUpdate on Infective Endocarditis
Bashore, T. M., Cabell, C. H., & Fowler, V. G. (2006) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2005.12.001 · Cited by 244
Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity
Avent, M. L., Rogers, B. A., Cheng, A. C., & Paterson, D. L. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2011.02452.x · Cited by 230
Bliziotis, I. A., Samonis, G., Vardakas, K. Z., Chrysanthopoulou, S. A., & Falagas, M. E. (2005) · Clinical Infectious Diseases · doi:10.1086/430912 · Cited by 219
Pharmacodynamics and dosing of aminoglycosides
Turnidge, J. D. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(03)00057-6 · Cited by 192
Edson, R. S., & Terrell, C. L. (1999) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)65134-3 · Cited by 153
Unique Features of Infective Endocarditis in Childhood
Ferrieri, P., Gewitz, M. H., Gerber, M. A., Newburger, J. W., Dajani, A. S., Shulman, S. T., Wilson, W., Bolger, A. F., Bayer, A. S., Levison, M. E., et al. (2002) · PEDIATRICS · doi:10.1542/peds.109.5.931 · Cited by 149
Self-citationEndocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00082-5 · Cited by 144
Falagas, M. E., Matthaiou, D. K., & Bliziotis, I. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl044 · Cited by 142
Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients
Hayashi, Y., & Paterson, D. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir063 · Cited by 138
Progress toward a global understanding of infective endocarditis
Cabell, C. H., & Abrutyn, E. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00007-1 · Cited by 137
A uncommon cause of angina during upper limb exercise.
Speciale, G., Pristipino, C., Pasceri, V., Irini, D., Pelliccia, F., Granatelli, A., Pironi, B., Roncella, A., & Richichi, G. (2004) · PubMed · Cited by 136
Andrews, M., & von Reyn, C. F. (2001) · Clinical Infectious Diseases · doi:10.1086/321814 · Cited by 129
Lamb, H. M., Ormrod, D. J., Scott, L. J., & Figgitt, D. P. (2002) · Drugs · doi:10.2165/00003495-200262070-00005 · Cited by 127
Hanretty, A. M., & Gallagher, J. C. (2018) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2118 · Cited by 123
Prophylaxe der infektiösen Endokarditis
Naber, C. K., Al-Nawas, B., Baumgartner, H., Becker, H.-J., Block, M., Erbel, R., Ertl, G., Flückiger, U., Franzen, D., Gohlke-Bärwolf, C., et al. (2007) · Der Kardiologe · doi:10.1007/s12181-007-0037-x · Cited by 120
Guidelines for Diagnosis and Management of Infective Endocarditis in Adults
McDonald, E. G., Aggrey, G., Aslan, A. T., Casias, M., Cortes-Penfield, N. W., Dong, M. Q., Egbert, S., Footer, B. W., Isler, B., King, M. A., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.26366 · Cited by 122
Combination Antibiotic Therapy for Infective Endocarditis
Le, T., & Bayer, A. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367661 · Cited by 117
Paul, M., Grozinsky‐Glasberg, S., Soares‐Weiser, K., & Leibovici, L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003344.pub2 · Cited by 114
Tsuji, B. T., & Rybak, M. J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2735-2745.2005 · Cited by 113
Quality measures of antimicrobial drug use
Gyssens, I. C. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00208-9 · Cited by 112
Current best practices and guidelines
Sexton, D. J., & Spelman, D. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00031-6 · Cited by 102
Self-citationEdson, R. S., & Terrell, C. L. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.5.519 · Cited by 96
Horstkotte, D., (Alemania), C., Folláth, F., Gutschik, E., Lengyel, M., Oto, A., Pavie, A., Soler‐Soler, J., Thiene, G., & von Graevenitz, A. (2004) · Revista Española de Cardiología · doi:10.1016/s0300-8932(04)77224-3 · Cited by 96
Domenico, E. G. D., Rimoldi, S. G., Cavallo, I., D’Agosto, G., Trento, E., Cagnoni, G., Palazzin, A., Pagani, C., Romeri, F., Vecchi, E. D., et al. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1596-2 · Cited by 92
Infective Endocarditis in Elderly Patients
Dhawan, V. K. (2002) · Clinical Infectious Diseases · doi:10.1086/339045 · Cited by 87
Clinical implications of β-lactam–aminoglycoside synergism: systematic review of randomised trials
Marcus, R., Paul, M., Elphick, H., & Leibovici, L. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.029 · Cited by 79
Proposal for shorter antibiotic therapies
Wintenberger, C., Guery, B. P., Bonnet, É., Castan, B., Cohen, R., Diamantis, S., Lesprit, P., Maulin, L., Pean, Y., Péju, E., et al. (2017) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2017.01.007 · Cited by 79
Role of aminoglycosides in the treatment of bacterial endocarditis
Graham, J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.437 · Cited by 77
Cervera, C., del Rı́o, A., García, L., Sala, M., Almela, M., Moreno, A., Falces, C., Mestres, C. A., Marco, F., Robau, M., et al. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.05.007 · Cited by 72
Current use for old antibacterial agents: polymyxins, rifampin, and aminoglycosides
Kaye, D. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.007 · Cited by 70
s, J. M. P., Llopis, J., Ramallo, V. J. G., Goenaga, M. Á., Muñóz, P., García-Leoni, M. E., Fariñas, M. C., Pajarón, M., Ambrosioni, J., Luque, R., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz030 · Cited by 73
Aminoglycosides for infective endocarditis: time to say goodbye?
Lebeaux, D., Fernández‐Hidalgo, N., Pilmis, B., Tattevin, P., & Mainardi, J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.10.017 · Cited by 66
Infective endocarditis: trends, surgical outcomes, and controversies
Jamil, M., Sultan, I. S., Gleason, T. G., Navid, F., Fallert, M., Suffoletto, M. S., & Kilic, A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.45 · Cited by 59
Swedish guidelines for diagnosis and treatment of infective endocarditis
Westling, K., Aufwerber, E., Ekdahl, C., Friman, G., Gårdlund, B., Julander, I., Olaison, L., Olesund, C., Rundström, H., Snygg‐Martin, U., et al. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701534517 · Cited by 65
Epidemiology and antibiotic treatment of infective endocarditis: an update
Hoen, B. (2006) · Heart · doi:10.1136/hrt.2005.072595 · Cited by 60
Amodeo, M. R., Clulow, T., Lainchbury, J. G., Murdoch, D., Gallagher, K., Dyer, A., Metcalf, S. C. L., Pithie, A. D., & Chambers, S. T. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.009 · Cited by 58
S2-Leitlinie zur Diagnostik und Therapie der infekti�sen Endokarditis
Naber, C. K., Christoph K. Naber (1), A. B., & Herausgegeben von der Paul-Ehrlich-Gesellschaft f�r Chemotherapie (PEG) und dem Vorstand der Deutschen Gesellschaft f�r Kardiologie, H. U. K. (. I. Z. M. D. D. G. F. T. (2004) · Zeitschrift für Kardiologie · doi:10.1007/s00392-004-0183-0 · Cited by 57
Definite Streptococcus bovis endocarditis: characteristics in 20 patients
Duval, X., Papastamopoulos, V., Longuet, P., Benoit, C., Perronne, C., Leport, C., & Vildé, J. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.00190.x · Cited by 54
ONCE-DAILY DOSING OF AMINOGLYCOSIDE ANTIBIOTICS
Fisman, D. N., & Kaye, K. M. (2000) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70259-2 · Cited by 53
Infectious endocarditis and infection of intracardiac devices in adults. Clinical guidelines 2021
Демин, А. А., Kobalava, Z. D., Skopin, I. I., Tyurin, P. V., Boytsov, S. A., Golukhova, E. Z., Гордеев, М. Л., Gudymovich, V. D., Demchenko, E. A., Дробышева, В. П., et al. (2022) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2022-5233 · Cited by 64
Special issues in the management of infective endocarditis caused by Gram-positive cocci
Hoen, B. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00004-6 · Cited by 51
Progress toward a global understanding of infective endocarditis
Cabell, C. H., & Abrutyn, E. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00033-x · Cited by 49
Management of Aminoglycosides in the Intensive Care Unit
Radigan, E., Gilchrist, N. A., & Miller, M. A. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610377968 · Cited by 47
Hagihara, M., Crandon, J. L., & Nicolau, D. P. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.632631 · Cited by 42
Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy
Tice, A. D., Rehm, S. J., Dalovisio, J. R., Bradley, J. S., Martinelli, L. P., Graham, D. R., Gainer, R. B., Kunkel, M. J., Yancey, R. W., & Williams, D. N. (2004) · Journal of Infusion Nursing · doi:10.1097/00129804-200409000-00008 · Cited by 41
Self-citationA review of current treatment strategies for infective endocarditis
Paz, D. L., Lakbar, I., & Tattevin, P. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1822165 · Cited by 39
Infective endocarditis – A review of current therapy and future challenges
Rezar, R., Lichtenauer, M., Haar, M., Hödl, G., Kern, J. M., Zhou, Z., Wuppinger, T., Kraus, J., Strohmer, B., Hoppe, U. C., et al. (2020) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2020.10.007 · Cited by 56
Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides
Chen, L. F., & Kaye, D. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.03.007 · Cited by 35
Current best practices and guidelines
Sexton, D. J., & Spelman, D. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00011-3 · Cited by 35
Self-citationEsposito, S., Esposito, I., & Leone, S. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks277 · Cited by 34
A comparison of different antibiotic regimens for the treatment of infective endocarditis
Martí-Carvajal, A. J., Dayer, M., Conterno, L. D. O., Garay, A. G. G., Martí-Amarista, C. E., & Simancas‐Racines, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009880.pub2 · Cited by 33
Principles of Anti-Infective Therapy
Eliopoulos, G. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00287-6 · Cited by 31
Lemaignen, A., Bernard, L., Tattevin, P., Bru, J. P., Duval, X., Hoen, B., Brunet-Houdard, S., Mainardi, J., & Caille, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033540 · Cited by 30
A comparison of different antibiotic regimens for the treatment of infective endocarditis
Martí-Carvajal, A. J., Dayer, M., Conterno, L. D. O., Garay, A. G. G., & Martí-Amarista, C. E. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009880.pub3 · Cited by 34
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00077-1 · Cited by 28
Audits for Monitoring the Quality of Antimicrobial Prescriptions
Gyssens, I. C. (2005) · Springer eBooks · doi:10.1007/0-387-22852-7_12 · Cited by 27
Wilson, W. R. (1998) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1998.tb00863.x · Cited by 27
Self-citationOutpatient management of infective endocarditis
Monteiro, C.-A., & Cobbs, C. G. (2001) · Current Infectious Disease Reports · doi:10.1007/s11908-001-0068-6 · Cited by 26
Benedetto, U., Spadaccio, C., Gentile, F., Moon, M. R., & Nappi, F. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3880 · Cited by 26
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73131-8 · Cited by 25
Shelburne, S. A., Greenberg, S. B., Aslam, S., & Tweardy, D. J. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.05.010 · Cited by 23
Bîrluțiu, V., Bîrluţiu, R. M., & Costache, V. S. (2018) · Medicine · doi:10.1097/md.0000000000011260 · Cited by 23
German guidelines for the diagnosis and management of infective endocarditis
(2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.01.017 · Cited by 22
Antimicrobial Therapy of Sepsis and Septic Shock—When Are Two Drugs Better Than One?
Abad, C. L. R., Kumar, A., & Safdar, N. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.12.001 · Cited by 19
Østergaard, L., Pries‐Heje, M. M., Hasselbalch, R. B., Rasmussen, M., Åkesson, P., Horvath, R. L., Povlsen, J. A., Gill, S. U. A., Bruun, N. E., Müllertz, K. M., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.05.012 · Cited by 21
Principles of Anti-infective Therapy
Pillai, S. K., Eliopoulos, G. M., & Moellering, R. C. (2010) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-0-443-06839-3.00018-7 · Cited by 21
Management of Endocarditis: Outpatient Parenteral Antibiotic Treatment in Argentina
Lopardo, G. D. (2000) · Chemotherapy · doi:10.1159/000048565 · Cited by 20
Verhagen, D. W. M., Vedder, A. C., Speelman, P., & van der Meer, J. T. M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl087 · Cited by 20
New developments in the treatment of infective endocarditis (infective cardiovasculitis)
Gutschik, E. (1999) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00110-7 · Cited by 20
Infective endocarditis in elderly patients
Dhawan, V. K. (2003) · Current Infectious Disease Reports · doi:10.1007/s11908-003-0004-z · Cited by 19
Endocarditis at the Millennium
Hoesley, C. J., & Cobbs, C. G. (1999) · The Journal of Infectious Diseases · doi:10.1086/513840 · Cited by 19
Craig, W. A., & Andes, D. R. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00021-7 · Cited by 18
Treatment and prevention of infective endocarditis
Roth, O., Delahaye, F., Hoen, B., McFadden, E. P., & de Gévigney, G. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.2.131 · Cited by 18
Infective endocarditis: Updated guidelines
Allen, U., & Canadian Paediatric Society (2010) · Paediatrics & Child Health · doi:10.1093/pch/15.4.205 · Cited by 17
Impact of Valve Culture in the Prognosis of Active Left-sided Infective Endocarditis
García-Granja, P. E., López, J., Vilacosta, I., Sarriá, C., Ladrón, R., Olmos, C., Sáez, C., Maroto, L. C., Stefano, S. D., Gómez, I., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy684 · Cited by 17
Self-citationOnce-Daily Aminoglycosides in the Treatment of Gram-Positive Endocarditis
Tam, V. H., Preston, S. L., & Briceland, L. L. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18316 · Cited by 17
Outpatient treatment of infective endocarditis
Francioli, P. B., & Stamboulián, D. (1998) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1998.tb00866.x · Cited by 16
Leibovici, L. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.006 · Cited by 15
Infective Endocarditis: Updated Guidelines
Allen, U. (2010) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2010/760276 · Cited by 14
Astigarraga, P. M. O., Garnacho‐Montero, J., Grau, S., Colomo, Ó. R., Palomar, M., Zaragoza, R., García-Paredes, P. M., Cerdá, E., & Lerma, F. Á. (2007) · Medicina Intensiva · doi:10.1016/s0210-5691(07)74829-5 · Cited by 13
Clinical Guideline for the Diagnosis and Treatment of Cardiovascular Infections
The Korean Society of Infectious Diseases, Korean Society for Chemotherapy, The Korean Society of Cardiology, & The Korean Society for Thoracic and Cardiovascular Surgery (2011) · Infection and Chemotherapy · doi:10.3947/ic.2011.43.2.129 · Cited by 13
CalcDose: A Software for Drug Dosage Conversion Using Metabolically Active Mass of Animals
Khan, H. A. (2003) · Drug and Chemical Toxicology · doi:10.1081/dct-120017557 · Cited by 12
Metadata
- Authors
- Sexton, D. J., Tenenbaum, M. J., Wilson, W. R., Steckelberg, J. M., Tice, A. D., Gilbert, D., Dismukes, W., Drew, R. H., Durack, D. T., & Endocarditis Treatment Consortium Group
- Affiliations
- Duke Medical Center (US)
- Mayo Clinic (US)
- Corresponding author
- Sexton, Daniel J.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-12-01
- Volume
- 27
- Issue
- 6
- Pages
- 1470-1474
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1976043895
- Semantic Scholar
- 048ac2cb5b05b0d8ad8cedd6c53ecd0245719ee6
- Cited by
- 195
- References
- 16
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 1 · 2021: 2 · 2020: 8 · 2019: 5 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 9 · 2014: 5 · 2013: 3 · 2012: 3
- FWCI
- 5.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- ceftriaxone, gentamicin, streptococcal endocarditis, antibiotic monotherapy, combination antibiotic therapy, intravenous antibiotics, treatment efficacy, treatment safety, cardiac surgery
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Ceftriaxone, Cephalosporins, Drug Therapy, Combination, Endocarditis, Bacterial, Gentamicins, Humans, Middle Aged, Penicillins, Streptococcal Infections, Streptococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
